FDA Orange Book · active-ingredient family
Calcium chloride; dextrose; potassium chloride; sodium chloride
Calcium chloride; dextrose; potassium chloride; sodium chloride is approved in 4 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER · NDA 020000
4
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER | B BRAUN | NDA 020000 | — | Apr 17, 1992 | |
| DEXTROSE 5% AND RINGER'S IN PLASTIC CONTAINER | HOSPIRA | NDA 018254 | — | Approved Prior to Jan 1, 1982 | |
| DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER | B BRAUN | NDA 018256 | — | Approved Prior to Jan 1, 1982 | |
| DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER | BAXTER HLTHCARE | NDA 016695 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Calcium chloride; dextrose; potassium chloride; sodium chloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
